Dr. Omar Salah Aljitawi, MD

Dr. Aljitawi practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Aljitawi's NPI, 1013018415, was assigned on September 26, 2006. Dr. Aljitawi holds New York license 284796.

Dr. Aljitawi's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Aljitawi's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. Aljitawi is also affiliated with F.F. Thompson Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Aljitawi to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aljitawi practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Aljitawi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Aljitawi is licensed in New York.

CMS data shows 292 Medicare services from Dr. Aljitawi across 5 procedure codes in 2024, for 74 Medicare patients. Medicare paid $24,966 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 74 Medicare patients who saw Dr. Aljitawi in 2024. The largest group is 65 to 74, with 50 patients. 74% of them have high blood pressure, and 68% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aljitawi's median patient age at 66, with 40% women.

In 2024, Dr. Aljitawi wrote 696 Medicare Part D claims for 59 patients. 75% of them were for generic drugs. CMS names the drug for 516 of them, across 18 drugs with 11 or more claims each, at $1,478,629 in total drug cost. In 2023, CMS named 488 claims across 20 drugs.

Dr. Aljitawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 58 papers to Dr. Aljitawi, published from 2011 to 2023. 2015 was the busiest year, with 8. The most frequent topics are Hematopoietic Stem Cell Transplantation, Cell Differentiation and Graft vs Host Disease. Dr. Aljitawi has published most often in Cancers (Basel). Dr. Aljitawi's most frequent co-authors are Sunil H. Abhyankar, MD, Tara L. Lin, MD and Siddhartha Ganguly, MD.

Dmand AI links Dr. Aljitawi to 1 clinical trial. Conditions studied include Multiple Myeloma and Blood Protein Disorders.

CMS Open Payments shows 5 general payments to Dr. Aljitawi from 3 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 48% of the total. National Marrow Donor Program paid the most, $498.